Delivery Order SPE2DB22D1106-SPE2DB24FFBH1
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.40 firm fixed-price delivery order is for 4563118550 Buprenorphine 15 MCG/HR Patch 4S, a specialty medication. The award has an ultimate completion date of December 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DX15D2213|SPE2DX24F7X9X, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,954,459 units of Buprenorphine 20 mcg/hr Patches. The award has a ceiling value of $1,056.00 and an ultimate completion date of December 1, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Buprenorphine 20 mcg/hr transdermal patches. The $2,056.78 contract has a completion date of July 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,535.19, is for the delivery of Buprenorphine 20 MCG/HR Patch 4S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of October 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award is for the delivery of Buprenorphine 20 mcg/hr patches to the Defense Logistics Agency (DLA). The $1,658.72 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 13, 2023. The contract has an ultimate completion date of April 14, 2023 and was not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,211.02 to supply Buprenorphine 20 mcg/hr patches. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by November 15, 2023. No set-aside designation was applied to this award made against an existing DLA contract vehicle. Amerisourcebergen provides pharmaceuticals and medical...
This federal contract award is for the delivery of Buprenorphine 20 mcg/hr Patches to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with no set-aside designation, indicating open competition. The contract has a ceiling value of $2,519.08 and an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
This federal contract award SPE2DB20D1109|SPE2DB23FP08V was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,255.16 firm fixed-price delivery order is for the supply of 4560861778 BUPRENORPHINE 10 MCG/HR PATCH 4S, a medication used for pain management. The contract has an ultimate completion date of May 9, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of BUPRENORPHINE 20 MCG/HR PATCH 4S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 17, 2024 with a ceiling value of $1,211.98. The contract is a Delivery Order under a Firm Fixed Price arrangement and has an ultimate completion date of October 18, 2024. This award is not designated as a set-aside...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,093.06 award is for the delivery of BUPRENORPHINE 20 MCG/HR PATCH 4S, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance...